Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010.
Vitamin A and systemic inflammation as protective factors in multiple sclerosis.
Modeling of cognitive impairment by disease duration in multiple sclerosis: a cross-sectional study.
Activities of daily living: evaluation and treatment in persons with multiple sclerosis.
Death receptor 6 negatively regulates oligodendrocyte survival, maturation and myelination.
Delayed onset adenosine deaminase deficiency associated with acute disseminated encephalomyelitis.
Subcellular distribution of FTY720 and FTY720-phosphate in immune cells - another aspect of Fingolimod action relevant for therapeutic application.
Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives.
Disability weight for each level of the Expanded Disability Status Scale in multiple sclerosis.
Gray matter is targeted in first-attack multiple sclerosis.
Vitamin D: a natural inhibitor of multiple sclerosis.
In vitro screening of NADPH oxidase inhibitors and in vivo effects of L-leucinethiol on experimental autoimmune encephalomyelitis-induced mice.
An Inventory of Short Term and Long Term Changes in Gene Expression Under Interferon β Treatment of Relapsing Remitting MS Patients.
Impact of Fingolimod Therapy on Magnetic Resonance Imaging Outcomes in Patients With Multiple SclerosisImpact of Fingolimod Therapy in Multiple Sclerosis.
Submembranous cytoskeletons stabilize nodes of Ranvier.
Long-Term Results Underscore Value of Early MS Treatment
Patient Perspectives and Experience with Dalfampridine Treatment in Multiple Sclerosis-Related Walking Impairment: The Step Together Program.
The role of laquinimod in modulation of the immune response in relapsing-remitting multiple sclerosis: Lessons from gene expression signatures.
Sleep Disorders and Multiple Sclerosis: A Clinical and Polysomnography Study.
Neuromyelitis Optica Following Human Papillomavirus Vaccination.
Current Immune Therapies of Autoimmune Disease of the Nervous System with Special Emphasis to Multiple Sclerosis.
Oligodendrocytes Enforce Immune Tolerance of the Uninfected Brain by Purging the Peripheral Repertoire of Autoreactive CD8(+) T Cells.
Genzyme to Resubmit LemtradaTM Application for FDA Review
Substance Name: Naltrexone
Separated at birth? The functional and molecular divergence of OLIG1 and OLIG2.

Pages